Polynucleotides encoding anti-CD20 antigen binding molecules with increased Fc receptor binding affinity and effector function

Patent metadata

Field	Value
Publication number	US-9296820-B2
Application number	US-98173804-A
Country	US
Kind code	B2
Filing date	Nov 5, 2004
Priority date	Nov 5, 2003
Publication date	Mar 29, 2016
Grant date	Mar 29, 2016

Abstract

The present invention relates to nucleic acids encoding anti-CD20 antigen binding molecules (ABMs). In particular embodiments, the present invention relates to nucleic acid encoding recombinant monoclonal antibodies, including chimeric, primatized or humanized antibodies specific for human CD20. In some embodiments, the invention relates to an isolated polynucleotide comprising a) a sequence encoding a polypeptide having a sequence selected from the group consisting of SEQ ID NO:40; SEQ ID NO:32; SEQ ID NO:56; and SEQ ID NO:60; and b) a sequence encoding a polypeptide having the sequence of SEQ ID NO:76. In addition, the present invention relates to vectors and host cells comprising such nucleic acid molecules. The invention further relates to methods for producing the ABMs of the invention. In addition, the present invention relates to ABMs with modified glycosylation having improved therapeutic properties, including antibodies with increased Fc receptor binding and increased effector function.

First claim

What is claimed is:

1. An isolated polynucleotide comprising
a) a sequence encoding a polypeptide having a sequence selected from the group consisting of SEQ ID NO:40; SEQ ID NO:32; SEQ ID NO:56; and SEQ ID NO:60; and
b) a sequence encoding a polypeptide having the sequence of SEQ ID NO:76.

2. A composition comprising an isolated first polynucleotide that encodes a polypeptide that comprises an immunoglobulin heavy chain variable region comprising the amino acid sequence of SEQ ID NO:40, and an isolated second polynucleotide that encodes a polypeptide that comprises an immunoglobulin light chain variable region comprising the amino acid sequence of SEQ ID NO:76.

3. An in vitro cultured host cell comprising a first polynucleotide that encodes a polypeptide that comprises an immunoglobulin heavy chain variable region comprising the amino acid sequence of SEQ ID NO:40, and a second polynucleotide that encodes a polypeptide that comprises an immunoglobulin light chain variable region comprising the amino acid sequence of SEQ ID NO:76.

4. The isolated polynucleotide of claim 1 , wherein said polypeptide of a) has a sequence of SEQ ID NO:40.

5. The isolated polynucleotide of claim 1 , wherein said sequence encoding the polypeptide of a) further encodes a human Fc region.

6. The isolated polynucleotide of claim 5 , wherein said human Fc region is a human IgG Fc region.

7. The composition of claim 2 , wherein said first polynucleotide further encodes a human Fc region.

8. The composition of claim 7 , wherein said human Fc region is a human IgG Fc region.

9. The in vitro cultured host cell of claim 3 , wherein said first polynucleotide further encodes a human Fc region.

10. The in vitro cultured host cell of claim 9 , wherein said human Fc region is a human IgG Fc region.

11. The in vitro cultured host cell of claim 3 , wherein said host cell is a mammalian cell or a yeast cell.

12. The in vitro cultured host cell of claim 3 , wherein said host cell is a Chinese hamster ovary (CHO) cell.

13. An in vitro cultured host cell comprising
a) a polynucleotide encoding a polypeptide comprising an amino acid sequence selected from the group consisting of SEQ ID NO:40; SEQ ID NO:32; SEQ ID NO:56; and SEQ ID NO:60; and
b) a polynucleotide encoding a polypeptide comprising the amino acid sequence of SEQ ID NO:76.

14. The in vitro cultured host cell of claim 13 , wherein said polynucleotide of a) encodes a polypeptide having the amino acid sequence of SEQ ID NO:40.

15. The in vitro cultured host cell of claim 13 , wherein said polynucleotide of a) further encodes a human Fc region.

16. The in vitro cultured host cell of claim 15 , wherein said human Fc region is a human IgG Fc region.

17. The in vitro cultured host cell of claim 13 , wherein said host cell is a mammalian cell or a yeast cell.

18. The in vitro cultured host cell of claim 13 , wherein said host cell is a CHO cell.

19. The in vitro cultured host cell of claim 13 , wherein the host cell produces an antibody encoded by said polynucleotides of a) and b).

20. A CHO cell comprising a polynucleotide encoding a polypeptide comprising the amino acid sequence of SEQ ID NO:40, and a polynucleotide encoding a polypeptide comprising the amino acid sequence of SEQ ID NO:76.

21. The CHO cell of claim 20 , wherein the cell produces an antibody encoded by said polynucleotides.

22. An expression vector comprising a polynucleotide comprising
a) a sequence encoding a polypeptide having the sequence of SEQ ID NO:40; and
b) a sequence encoding a polypeptide having the sequence of SEQ ID NO:76.

Assignees

• Umaña Pablo
• Brünker Peter
• Ferrara Koller Claudia
• Suter Tobias
• Püntener Ursula
• Mössner Ekkehard
• Roche Glycart Ag

Inventors

• Umaña Pablo
• Brünker Peter
• Ferrara Koller Claudia
• Suter Tobias
• Püntener Ursula
• Mössner Ekkehard

Classifications

• A61P5/40

  Mineralocorticosteroids, e.g. aldosterone; Drugs increasing or potentiating the activity of mineralocorticosteroids · CPC title

• A61P37/00

  Drugs for immunological or allergic disorders · CPC title

• A61P43/00

  Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00 · CPC title

• A61P35/00

  Antineoplastic agents · CPC title

• A61P37/02

  Immunomodulators · CPC title